Inhibitor Therapeutics, Inc. (INTI) stock
INTIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.11+0.00 (+0.09%)
Close on Oct 19, 2026Market cap $19.06MP/E –Yield –
Inhibitor Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Inhibitor Therapeutics's total debt was $47.83K at Jun 30, 2026. For fiscal 2025 it was $61.61K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.61K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $47.83K | -38.7% |
| Q1 FY2026 | Mar 31, 2026 | $58.36K | -30.8% |
| Q4 FY2025 | Dec 31, 2025 | $61.61K | – |
| Q3 FY2025 | Sep 30, 2025 | $71.64K | – |
| Q2 FY2025 | Jun 30, 2025 | $78.05K | – |
| Q1 FY2025 | Mar 31, 2025 | $84.35K | – |
See a number that looks wrong?